Pacific Bio (PACB) Misses Q2 EPS by 1c
Get Alerts PACB Hot Sheet
Join SI Premium – FREE
Pacific Bio (NASDAQ: PACB) reported Q2 EPS of ($0.21), $0.01 worse than the analyst estimate of ($0.20). Revenue for the quarter came in at $30.6 million versus the consensus estimate of $29.89 million.
For earnings history and earnings-related data on Pacific Bio (PACB) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Pacific Biosciences of California (PACB) PT Lowered to $8 at Scotiabank
- Pacific Biosciences of California (PACB) PT Lowered to $3.50 at Canaccord Genuity
- Growth isn't weak enough to truly undercut inflation pressures - BMO
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!